Allergy immunotherapy

Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is anticipated to grow from USD 1.70 billion in 2023 to USD 3.20 billion by 2030, exhibiting a…

<!-- Name:DistributionId Value:8843075 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4533 -->…

<!-- Name:DistributionId Value:1000800325 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5555 -->…

- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against allergic and inflammatory diseases, today…

- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against allergic and…

New York, Nov. 17, 2021 (GLOBE NEWSWIRE) -- A recent article in the peer-reviewed journal International Forum of Allergy and Rhinology reported the results of a survey offered to individuals with allergic rhinitis. Sarita S. Ballakur MD,…